13 research outputs found
Interaction of Scaffolding Adaptor Protein Gab1 with Tyrosine Phosphatase SHP2 Negatively Regulates IGF-I-dependent Myogenic Differentiation via the ERK1/2 Signaling Pathway*S⃞
Grb2-associated binder 1 (Gab1) coordinates various receptor tyrosine
kinase signaling pathways. Although skeletal muscle differentiation is
regulated by some growth factors, it remains elusive whether Gab1 coordinates
myogenic signals. Here, we examined the molecular mechanism of insulin-like
growth factor-I (IGF-I)-mediated myogenic differentiation, focusing on Gab1
and its downstream signaling. Gab1 underwent tyrosine phosphorylation and
subsequent complex formation with protein-tyrosine phosphatase SHP2 upon IGF-I
stimulation in C2C12 myoblasts. On the other hand, Gab1 constitutively
associated with phosphatidylinositol 3-kinase regulatory subunit p85. To
delineate the role of Gab1 in IGF-I-dependent signaling, we examined the
effect of adenovirus-mediated forced expression of wild-type Gab1
(Gab1WT), mutated Gab1 that is unable to bind SHP2
(Gab1ΔSHP2), or mutated Gab1 that is unable to bind p85
(Gab1Δp85), on the differentiation of C2C12 myoblasts.
IGF-I-induced myogenic differentiation was enhanced in myoblasts
overexpressing Gab1ΔSHP2, but inhibited in those
overexpressing either Gab1WT or Gab1Δp85.
Conversely, IGF-I-induced extracellular signal-regulated kinase 1/2 (ERK1/2)
activation was significantly repressed in myoblasts overexpressing
Gab1ΔSHP2 but enhanced in those overexpressing either
Gab1WT or Gab1Δp85. Furthermore, small
interference RNA-mediated Gab1 knockdown enhanced myogenic differentiation.
Overexpression of catalytic-inactive SHP2 modulated IGF-I-induced myogenic
differentiation and ERK1/2 activation similarly to that of
Gab1ΔSHP2, suggesting that Gab1-SHP2 complex inhibits
IGF-I-dependent myogenesis through ERK1/2. Consistently, the blockade of
ERK1/2 pathway reversed the inhibitory effect of Gab1WT
overexpression on myogenic differentiation, and constitutive activation of the
ERK1/2 pathway suppressed the enhanced myogenic differentiation by
overexpression of Gab1ΔSHP2. Collectively, these data suggest
that the Gab1-SHP2-ERK1/2 signaling pathway comprises an inhibitory axis for
IGF-I-dependent myogenic differentiation